Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective

Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective

Bibliographic Details
Main Authors: B. Aniketh Vijay, T. Rajesh, Devu Pavithran, Sreya Pushpan
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Indian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483217305977
id doaj-fd713b58a2de473d8f9d8ef1263aae0d
record_format Article
spelling doaj-fd713b58a2de473d8f9d8ef1263aae0d2020-11-25T00:31:53ZengElsevierIndian Heart Journal0019-48322017-11-0169S2S9410.1016/j.ihj.2017.09.016Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspectiveB. Aniketh VijayT. RajeshDevu PavithranSreya Pushpanhttp://www.sciencedirect.com/science/article/pii/S0019483217305977
collection DOAJ
language English
format Article
sources DOAJ
author B. Aniketh Vijay
T. Rajesh
Devu Pavithran
Sreya Pushpan
spellingShingle B. Aniketh Vijay
T. Rajesh
Devu Pavithran
Sreya Pushpan
Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective
Indian Heart Journal
author_facet B. Aniketh Vijay
T. Rajesh
Devu Pavithran
Sreya Pushpan
author_sort B. Aniketh Vijay
title Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective
title_short Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective
title_full Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective
title_fullStr Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective
title_full_unstemmed Outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: An institutional perspective
title_sort outcomes of type 2 diabetes mellitus patients with heart disease on empagliflozin in comparison with other anti-diabetic drugs: an institutional perspective
publisher Elsevier
series Indian Heart Journal
issn 0019-4832
publishDate 2017-11-01
url http://www.sciencedirect.com/science/article/pii/S0019483217305977
work_keys_str_mv AT banikethvijay outcomesoftype2diabetesmellituspatientswithheartdiseaseonempagliflozinincomparisonwithotherantidiabeticdrugsaninstitutionalperspective
AT trajesh outcomesoftype2diabetesmellituspatientswithheartdiseaseonempagliflozinincomparisonwithotherantidiabeticdrugsaninstitutionalperspective
AT devupavithran outcomesoftype2diabetesmellituspatientswithheartdiseaseonempagliflozinincomparisonwithotherantidiabeticdrugsaninstitutionalperspective
AT sreyapushpan outcomesoftype2diabetesmellituspatientswithheartdiseaseonempagliflozinincomparisonwithotherantidiabeticdrugsaninstitutionalperspective
_version_ 1725321899434573824

Similar Items